Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease.
Objective: The pharmacokinetic (PK) and pharmacodynamic (PD) responses to prasugrel were compared in three studies of healthy subjects vs. those with moderate or end-stage renal impairment. Methods: Two of the three protocols were parallel-design, open-label, single dose (60-mg prasugrel) studies in...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 34; no. 5; pp. 585 - 595 |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Oct2009
|
| Acceso en línea: | Ver este registro en EBSCOhost |